The statement engages in public discourse by addressing the issue of drug pricing in the U.S. and its impact on global healthcare economics. It suggests that Americans bear a significant portion of R&D costs, which affects drug prices.
Principle 1:
I will strive to do no harm with my words and actions.The statement does not directly harm but highlights a contentious issue, which could lead to discussions on healthcare policy.
Principle 3:
I will use my words and actions to promote understanding, empathy, and compassion.It attempts to promote understanding of why drug prices are high in the U.S., though it may not fully consider the complexities of international healthcare systems.
[+1]Principle 4:
I will engage in constructive criticism and dialogue with those in disagreement and will not engage in personal attacks or ad hominem arguments.The statement invites dialogue on healthcare economics, though it could be seen as oversimplifying the issue.